...
首页> 外文期刊>Neurosurgery >Contribution of bradykinin receptors to the development of secondary brain damage after experimental subarachnoid hemorrhage
【24h】

Contribution of bradykinin receptors to the development of secondary brain damage after experimental subarachnoid hemorrhage

机译:实验性蛛网膜下腔出血后缓激肽受体对继发性脑损伤发展的贡献

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Subarachnoid hemorrhage (SAH) is the stroke subtype with the highest mortality and morbidity. Which molecular events mediate brain damage after SAH is not well understood. OBJECTIVE: To investigate the role of proinflammatory bradykinin B1 and B2 receptors for the pathophysiology of SAH. METHODS: B1 and B2 receptor knockout or wild-type mice were subjected to SAH by endovascular puncture. Intracranial pressure, regional cerebral blood flow, and mean arterial blood pressure were continuously monitored up to 60 minutes after SAH. Brain water content was quantified 24 hours after SAH; mortality, neurological function, and body weight were assessed daily for 7 days after hemorrhage. RESULTS: Intracranial pressure, regional cerebral blood flow, and mean arterial blood pressure did not differ between groups. Mortality was 60% in wild-type mice and 82% in B 1R mice but only 20% in B 2R animals (P .05). B 2R mice also exhibited less severe neurological deficits (P .05), a less pronounced loss of body weight (P .05), and significantly less brain edema formation (P .05) compared with wild-type mice. CONCLUSION: Signaling mediated by bradykinin B 2 receptors contributes to mortality and secondary brain damage after SAH in mice. Thus, B 2 receptors may represent novel targets for the treatment of SAH.
机译:背景:蛛网膜下腔出血(SAH)是卒中的亚型,具有最高的死亡率和发病率。 SAH后哪些分子事件介导了脑损伤尚不清楚。目的:探讨促炎性缓激肽B1和B2受体在SAH病理生理中的作用。方法:通过血管内穿刺对B1和B2受体敲除或野生型小鼠进行SAH。在SAH后直​​至60分钟,要连续监测颅内压,局部脑血流量和平均动脉血压。 SAH后24小时定量脑水含量;出血后7天内每天评估死亡率,神经功能和体重。结果:两组之间的颅内压,局部脑血流量和平均动脉压没有差异。死亡率在野生型小鼠中为60%,在B 1R小鼠中为82%,但在B 2R动物中仅为20%(P <.05)。与野生型小鼠相比,B 2R小鼠还表现出较少的严重神经功能缺损(P <.05),较不明显的体重减轻(P <.05)和明显较少的脑水肿形成(P <.05)。结论:缓激肽B 2受体介导的信号传导导致SAH小鼠死亡和继发性脑损伤。因此,B 2受体可代表治疗SAH的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号